首页> 外文OA文献 >Cysteamine (Lynovex®), a novel mucoactive antimicrobial antibiofilm agent for the treatment of cystic fibrosis

【2h】

Cysteamine (Lynovex®), a novel mucoactive antimicrobial antibiofilm agent for the treatment of cystic fibrosis

机译：半胱胺（Lynovex®），一种新型的粘液活性抗微生物和抗生物膜剂，用于治疗囊性纤维化

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cysteamine (Lynovex?), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis [J] . Cedric Charrier, Catherine Rodger, Jennifer Robertson, Orphanet journal of rare diseases . 2014,第S1期

机译：半胱胺（Lynovex？），一种新型的粘液活性抗微生物和抗生物膜剂，用于治疗囊性纤维化
2. Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum [J] . Graham Devereux, Douglas Fraser-Pitt, Jennifer Robertson, EBioMedicine . 2015,第10期

机译：将氨基胺作为未来干预囊性纤维化对流动和新兴病原体的干预：基于患者的离体研究，证实其痰中的抗微生物和粘膜潜力
3. Mucoactive agents for chronic, non‐cystic fibrosis lung disease: A A systematic review and meta‐analysis [J] . Tarrant Benjamin J., Le Maitre Caitlin, Romero Lorena, Respirology : . 2017,第6期

机译：含有慢性，非囊性纤维化肺病的粘膜活性剂：一个系统审查和荟萃分析
4. Cystic fibrosis transmembrane conductance regulator gene mutations cause 'black' pigment gallstone formation: new insights from mouse models and implications for therapeutic interventions in cystic fibrosis [C] . A. L. BRODERICK, H. WITTENBURG, M. A. LYONS, Falk Symposium . 2004

机译：囊性纤维化跨膜电导调节剂基因突变引起'黑色'颜料胆结石形成：来自小鼠模型的新见解，以及对囊性纤维化治疗干预的影响
5. Liposomal antimicrobial agent formulations for the treatment of pulmonary infection in cystic fibrosis patients. [D] . Halwani, Majed Abdulaziz. 2010

机译：脂质体抗微生物剂制剂，用于治疗囊性纤维化患者的肺部感染。
6. Cysteamine (Lynovex®) a novel mucoactive antimicrobial antibiofilm agent for the treatment of cystic fibrosis [O] . Cedric Charrier, Catherine Rodger, Jennifer Robertson, 2014

机译：半胱胺（Lynovex®）一种新型的黏液活性抗微生物和抗生物膜剂用于治疗囊性纤维化
7. Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum [O] . Graham Devereux, Douglas Fraser-Pitt, Jennifer Robertson, 2015

机译：半胱胺作为针对当前和新出现的病原体的囊性纤维化的未来干预：基于患者的离体研究证实其在痰中的抗微生物和粘膜活性潜力

Cysteamine (Lynovex®), a novel mucoactive antimicrobial antibiofilm agent for the treatment of cystic fibrosis

著录项

引文网络

相似文献

相关主题

期刊订阅